Skip to menu Skip to content Skip to footer

2014

Journal Article

The epic3 recommendation that clinically indicated replacement of peripheral venous catheters is safe and cost-saving: how much would the NHS save?

Tuffaha, H. W., Rickard, C. M., Inwood, S., Gordon, L. and Scuffham, P. (2014). The epic3 recommendation that clinically indicated replacement of peripheral venous catheters is safe and cost-saving: how much would the NHS save?. Journal of Hospital Infection, 87 (3), 183-184. doi: 10.1016/j.jhin.2014.04.004

The epic3 recommendation that clinically indicated replacement of peripheral venous catheters is safe and cost-saving: how much would the NHS save?

2014

Journal Article

GCSF with or without chemotherapy compared to Plerixafor with GCSF as salvage mobilization regimen in patients with multiple myeloma and lymphoma: collection effectiveness and cost effectiveness analysis

Abdel-Rahman, Fawzi, Tuffaha, Haitham W, Sharma, Shanta, Jazar, Husam Abu, Hussein, Nilly, Saad, Adnan, Al Rawi, Omar and Hussein, Ayad (2014). GCSF with or without chemotherapy compared to Plerixafor with GCSF as salvage mobilization regimen in patients with multiple myeloma and lymphoma: collection effectiveness and cost effectiveness analysis. Journal of Oncology Pharmacy Practice, 20 (2), 130-136. doi: 10.1177/1078155213484785

GCSF with or without chemotherapy compared to Plerixafor with GCSF as salvage mobilization regimen in patients with multiple myeloma and lymphoma: collection effectiveness and cost effectiveness analysis

2014

Journal Article

Value of information analysis in healthcare: a review of principles and applications

Tuffaha, Haitham W., Gordon, Louisa G. and Scuffham, Paul A. (2014). Value of information analysis in healthcare: a review of principles and applications. Journal of Medical Economics, 17 (6), 377-383. doi: 10.3111/13696998.2014.907170

Value of information analysis in healthcare: a review of principles and applications

2014

Journal Article

Value of information analysis in oncology: the value of evidence and evidence of value

Tuffaha, Haitham W., Gordon, Louisa G. and Scuffham, Paul A. (2014). Value of information analysis in oncology: the value of evidence and evidence of value. Journal of Oncology Practice, 10 (2), e55-e62. doi: 10.1200/JOP.2013.001108

Value of information analysis in oncology: the value of evidence and evidence of value

2014

Journal Article

Cost-effectiveness analysis of clinically indicated versus routine replacement of peripheral intravenous catheters

Tuffaha, Haitham W., Rickard, Claire M., Webster, Joan, Marsh, Nicole, Gordon, Louisa, Wallis, Marianne and Scuffham, Paul A. (2014). Cost-effectiveness analysis of clinically indicated versus routine replacement of peripheral intravenous catheters. Applied Health Economics and Health Policy, 12 (1), 51-58. doi: 10.1007/s40258-013-0077-2

Cost-effectiveness analysis of clinically indicated versus routine replacement of peripheral intravenous catheters

2012

Journal Article

Revision and validation of a medication assessment tool for chronic cancer pain management

Salmany, Sewar S., Koopmans, Sara M., Treish, Imad M., El Jaber, Rana, Telfah, Shorouq and Tuffaha, Haitham W. (2012). Revision and validation of a medication assessment tool for chronic cancer pain management. The American Journal of Hospice and Palliative Medicine, 29 (8), 640-646. doi: 10.1177/1049909111435812

Revision and validation of a medication assessment tool for chronic cancer pain management

2012

Journal Article

Glucarpidase for the treatment of life-threatening methotrexate overdose

Tuffaha, H. W. and Al Omar, S. (2012). Glucarpidase for the treatment of life-threatening methotrexate overdose. Drugs of Today, 48 (11), 705-711. doi: 10.1358/dot.2012.48.11.1871575

Glucarpidase for the treatment of life-threatening methotrexate overdose

2012

Journal Article

Development and implementation of a method for characterizing clinical pharmacy interventions and medication use in a cancer center

Tuffaha, Haitham W and Koopmans, Sara M (2012). Development and implementation of a method for characterizing clinical pharmacy interventions and medication use in a cancer center. Journal of Oncology Pharmacy Practice, 18 (2), 180-185. doi: 10.1177/1078155211416529

Development and implementation of a method for characterizing clinical pharmacy interventions and medication use in a cancer center

2012

Journal Article

Clinical pharmacy services in the outpatient pediatric oncology clinics at a comprehensive cancer center

Tuffaha, Haitham W., Abdelhadi, Ola and Al Omar, Suha (2012). Clinical pharmacy services in the outpatient pediatric oncology clinics at a comprehensive cancer center. International Journal of Clinical Pharmacy, 34 (1), 27-31. doi: 10.1007/s11096-011-9600-4

Clinical pharmacy services in the outpatient pediatric oncology clinics at a comprehensive cancer center

2011

Journal Article

Glucarpidase rescue in a patient with high-dose methotrexate-induced nephrotoxicity

Tuffaha, Haitham W and Al Omar, Suha (2011). Glucarpidase rescue in a patient with high-dose methotrexate-induced nephrotoxicity. Journal of Oncology Pharmacy Practice, 17 (2), 136-40. doi: 10.1177/1078155209348720

Glucarpidase rescue in a patient with high-dose methotrexate-induced nephrotoxicity

2010

Journal Article

Successful stem-cell mobilization and transplantation using plerixafor in a patient with a germ cell tumor

Tuffaha, Haitham and Abdel-Rahman, Fawzi Abdel-Latif (2010). Successful stem-cell mobilization and transplantation using plerixafor in a patient with a germ cell tumor. Hematology/ Oncology and Stem Cell Therapy, 3 (4), 203-205. doi: 10.5144/1658-3876.2010.203

Successful stem-cell mobilization and transplantation using plerixafor in a patient with a germ cell tumor

2008

Journal Article

The use and effectiveness of granulocyte colony-stimulating factor in primary prophylaxis for febrile neutropenia in the outpatient setting

Tuffaha, Haitham W., Treish, Imad M. and Zaru, Luna (2008). The use and effectiveness of granulocyte colony-stimulating factor in primary prophylaxis for febrile neutropenia in the outpatient setting. Journal of Oncology Pharmacy Practice, 14 (3), 131-8. doi: 10.1177/1078155208091249

The use and effectiveness of granulocyte colony-stimulating factor in primary prophylaxis for febrile neutropenia in the outpatient setting